GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists
- First Posted Date
- 2007-03-14
- Last Posted Date
- 2012-06-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 32
- Registration Number
- NCT00447226
- Locations
- 🇺🇸
GSK Investigational Site, Vancouver, Washington, United States
A Study of GW842166 in Adults With Osteoarthritis Pain
- Conditions
- Osteoarthritis, Knee
- First Posted Date
- 2007-03-14
- Last Posted Date
- 2009-05-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 308
- Registration Number
- NCT00447486
- Locations
- 🇸🇪
GSK Investigational Site, Upplands Väsby, Sweden
This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge
- Conditions
- Asthma
- First Posted Date
- 2007-03-09
- Last Posted Date
- 2012-06-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 24
- Registration Number
- NCT00445510
- Locations
- 🇳🇿
GSK Investigational Site, Wellington, New Zealand
Dental Pain 3rd Molar Tooth Extraction GW842166
- Conditions
- Pain
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2009-05-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 112
- Registration Number
- NCT00444769
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.
- Conditions
- Asthma
- Interventions
- Drug: GW685698X containing magnesium stearate
- First Posted Date
- 2007-03-07
- Last Posted Date
- 2017-08-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 20
- Registration Number
- NCT00444509
- Locations
- 🇳🇿
GSK Investigational Site, Wellington, New Zealand
Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 29
- Registration Number
- NCT00442871
- Locations
- 🇺🇸
GSK Investigational Site, Saint Paul, Minnesota, United States
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 3002
- Registration Number
- NCT00443053
- Locations
- 🇺🇦
GSK Investigational Site, Zaporizhzhya, Ukraine
A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects
- Conditions
- Healthy SubjectsAnaemia
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2012-03-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 90
- Registration Number
- NCT00443170
- Locations
- 🇦🇺
GSK Investigational Site, Adelaide, South Australia, Australia
Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines
- Conditions
- Malaria
- Interventions
- Biological: GSK Malaria vaccine 257049
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2017-04-25
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 36
- Registration Number
- NCT00443131
- Locations
- 🇧🇪
GSK Investigational Site, Gent, Belgium
Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Other: Non-interventional study.
- First Posted Date
- 2007-03-02
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1283
- Registration Number
- NCT00442468
- Locations
- 🇺🇸
GSK Investigational Site, Tacoma, Washington, United States